Abstract
The aim of this study was to investigate the effect of circSnap47 on heart failure (HF) and its potential mechanisms. Quantitative real-time PCR (qRT-PCR) was performed to detect the mRNA expression levels of circSnap47 and miR-233-3p. The viability and apoptosis of H9C2 cells were assessed using CCK-8 and TUNEL assays. The expressions of interleukin (IL)-6, IL-1β, IL-18, and tumor necrosis factor-alpha were determined using ELISA and qRT-PCR. In addition, the expression of apoptosis-related proteins and mitogen-activated protein kinase (MAPK) signaling pathway-related proteins was analyzed using western blot. Moreover, HF-related circRNAs and miRNAs were predicted via bioinformatics analysis. The relationship between circSnap47 and miR-233-3p was further confirmed using a dual-luciferase reporter gene assay. In HF tissues and H9C2 cells treated with oxygen–glucose deprivation (OGD), circSnap47 was upregulated. Silencing circSnap47 increased cell viability and inhibited apoptosis. Besides, silencing circSnap47 alleviated OGD-induced inflammation in H9C2 cells. Moreover, we found that miR-233-3p was the downstream target gene of circSnap47. Our results also revealed that silencing circSnap47 relieved OGD-induced H9C2 cell damage by inactivating the miR-223-3p/MAPK axis. We confirmed that circSnap47 silencing inhibited HF progression via regulation of miR-223/MAPK axis, which will provide for a new therapeutic direction for the treatment of HF.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability
Not applicable.
References
Ahern RM, Lozano R, Naghavi M, Foreman K, Gakidou E, Murray CJ (2011) Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease. Popul Health Metrics 9:8
Braunwald E (2015) The war against heart failure: the Lancet lecture. Lancet (London, England) 385(9970):812–824
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB (2013) Heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation 127(1):e6–e245
Zhou B, Yu JW (2017) A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-β1. Biochem Biophys Res Commun 487(4):769–775
Zhang Y, Chen B (2021) Silencing circ_0062389 alleviates cardiomyocyte apoptosis in heart failure rats via modulating TGF-β1/Smad3 signaling pathway. Gene 766:145154
Deng Y, Wang J, Xie G, Zeng X, Li H (2019) Circ-HIPK3 Strengthens the Effects of Adrenaline in Heart Failure by MiR-17-3p–ADCY6 Axis. Int J Biol Sci 15(11):2484–2496
Chen X (2019) Expression of microRNA-3133 correlates with the prognosis in patients with clear cell renal cell carcinoma. Medicine 98(24):e16008
Long FQ, Kou CX, Li K, Wu J, Wang QQ (2020) MiR-223–3p inhibits rTp17-induced inflammasome activation and pyroptosis by targeting NLRP3. J Cellular Mol Med. https://doi.org/10.1111/jcmm.16061
Long C, Cen S, Zhong Z, Zhou C, Zhong G (2020) FOXO3 is targeted by miR-223–3p and promotes osteogenic differentiation of bone marrow mesenchymal stem cells by enhancing autophagy. Hum Cell. https://doi.org/10.1007/s13577-020-00421-y
Dai GH, Ma PZ, Song XB, Liu N, Zhang T, Wu B (2014) MicroRNA-223-3p inhibits the angiogenesis of ischemic cardiac microvascular endothelial cells via affecting RPS6KB1/hif-1a signal pathway. PLoS ONE 9(10):e108468
Sun Y, Jiang X, Lv Y, Liang X, Zhao B, Bian W, Zhang D, Jiang J, Zhang C (2020) Circular RNA expression profiles in plasma from patients with heart failure related to platelet activity. Biomolecules 10(2):187
Liu W, Zheng J, Dong J, Bai R, Song D, Ma X, Zhao L, Yao Y, Zhang H, Liu T (2018) Association of miR-197-5p, a circulating biomarker for heart failure, with myocardial fibrosis and adverse cardiovascular events among patients with stage C or D heart failure. Cardiology 141(4):212–225
Wong LL, Armugam A, Sepramaniam S, Karolina DS, Lim KY, Lim JY, Chong JP, Ng JY, Chen YT, Chan MM, Chen Z, Yeo PS, Ng TP, Ling LH, Sim D, Leong KT, Ong HY, Jaufeerally F, Wong R, Chai P, Low AF, Lam CS, Jeyaseelan K, Richards AM (2015) Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail 17(4):393–404
Zhang MW, Shen YJ, Shi J, Yu JG (2021) MiR-223-3p in Cardiovascular diseases: a biomarker and potential therapeutic target. Front Cardiovasc Med 7:610561
Ye CY, Zhang X, Chu Q, Liu C, Yu Y, Jiang W, Zhu QH, Fan L, Guo L (2017) Full-length sequence assembly reveals circular RNAs with diverse non-GT/AG splicing signals in rice. RNA Biol 14(8):1055–1063
Qu S, Yang X, Li X, Wang J, Gao Y, Shang R, Sun W, Dou K, Li H (2015) Circular RNA: a new star of noncoding RNAs. Cancer Lett 365(2):141–148
Zhong L, Wang Y, Cheng Y, Wang W, Lu B, Zhu L, Ma Y (2018) Circular RNA circC3P1 suppresses hepatocellular carcinoma growth and metastasis through miR-4641/PCK1 pathway. Biochem Biophys Res Commun 499(4):1044–1049
Zhou J, Zhang WW, Peng F, Sun JY, He ZY, Wu SG (2018) Downregulation of hsa_circ_0011946 suppresses the migration and invasion of the breast cancer cell line MCF-7 by targeting RFC3. Cancer Manag Res 10:535–544
Ma HB, Yao YN, Yu JJ, Chen XX, Li HF (2018) Extensive profiling of circular RNAs and the potential regulatory role of circRNA-000284 in cell proliferation and invasion of cervical cancer via sponging miR-506. Am J Transl Res 10(2):592–604
Han J, Zhang L, Hu L, Yu H, Xu F, Yang B, Zhang R, Zhang Y, An Y (2020) Circular RNA-expression profiling reveals a potential role of Hsa_circ_0097435 in heart failure via sponging multiple microRNAs. Front Genet 11:212
Kalogeropoulos A, Georgiopoulou V, Psaty BM, Rodondi N, Smith AL, Harrison DG, Liu Y, Hoffmann U, Bauer DC, Newman AB, Kritchevsky SB, Harris TB, Butler J (2010) Inflammatory markers and incident heart failure risk in older adults: the health ABC (health, aging, and body composition) study. J Am Coll Cardiol 55(19):2129–2137
Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D’Agostino RB (2003) Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 107(11):1486–1491
Van Tassell BW, Seropian IM, Toldo S, Mezzaroma E, Abbate A (2013) Interleukin-1β induces a reversible cardiomyopathy in the mouse. Inflamm Res 62(7):637–640
Chang H, Li C, Wang Q, Lu L, Zhang Q, Zhang Y, Zhang N, Wang Y, Wang W (2017) QSKL protects against myocardial apoptosis on heart failure via PI3K/Akt-p53 signaling pathway. Sci Rep 7(1):16986
Adams BD, Parsons C, Walker L, Zhang WC, Slack FJ (2017) Targeting noncoding RNAs in disease. J Clin Investig 127(3):761–771
Li J, Su H, Zhu Y, Cao Y, Ma X (2020) ETS2 and microRNA-155 regulate the pathogenesis of heart failure through targeting and regulating GPR18 expression. Exp Ther Med 19(6):3469–3478
Li DM, Li BX, Yang LJ, Gao P, Ma ZY, Li ZJD (2020) Diagnostic value of circulating microRNA-208a in differentiation of preserved from reduced ejection fraction heart failure. Heart Lung. https://doi.org/10.1016/j.hrtlng.2020.07.010
Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22(2):153–183
Li X, Wang G, QiLi M, Liang H, Li T, XiaoQiang E, Feng Y, Zhang Y, Liu X, Qian M, BoZhi X, Shen Z, Gitau SC, Zhao D, Shan H (2018) Aspirin Reduces Cardiac Interstitial Fibrosis by Inhibiting Erk1/2-Serpine2 and P-Akt Signalling Pathways. Cell Physiol 45(5):1955–1965
Song Y, Mai H, Lin Y, Wang Y, Wang X, Gu S (2020) MiR-144 affects proliferation and apoptosis of high glucose-induced AC16 cardiomyocytes by regulating CTRP3/JNK signaling. Int J Clin Exp Pathol 13(2):142–152
Li CY, Zhou Q, Yang LC, Chen YH, Hou JW, Guo K, Wang YP, Li YG (2016) Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway. Basic Res Cardiol 111(2):19
Funding
No Funding.
Author information
Authors and Affiliations
Contributions
YW: conception and design; PZ, HW, and LZ: perform research; PZ, JZ, and NL: data analysis and interpretation; YW: manuscript writing; All authors: final approval of manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Ethical approval and consent to participate
No human studies were carried out by the authors for this article. No animal studies were carried out by the authors for this article.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, Y., Wang, H., Zhang, L. et al. A novel identified circular RNA, circSnap47, promotes heart failure progression via regulation of miR-223-3p/MAPK axis. Mol Cell Biochem 478, 459–469 (2023). https://doi.org/10.1007/s11010-022-04523-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-022-04523-z